Back to top

BIOA Crosses Above Average Analyst Target

In recent trading, shares of BioAge Labs Inc (BIOA) have crossed above the average analyst 12-month target price of $4.67, changing hands for $4.68/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioAge Labs, Inc. (BIOA)